Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population

The Xpert HPV Assay (Xpert; Cepheid, Sunnyvale, CA) was developed for the multianalytic GeneXpert platform. In a colposcopy referral population of 708 women living in the United States, two cervical specimens, A and B, were collected, and both were tested by the Xpert assay for high-risk human papil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of clinical pathology 2015-01, Vol.143 (1), p.126-133
Hauptverfasser: Castle, Philip E, Smith, Katherine M, Davis, Thomas E, Schmeler, Kathleen M, Ferris, Daron G, Savage, Ashlyn H, Gray, Jermaine E, Stoler, Mark H, Wright, Jr, Thomas C, Ferenczy, Alex, Einstein, Mark H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133
container_issue 1
container_start_page 126
container_title American journal of clinical pathology
container_volume 143
creator Castle, Philip E
Smith, Katherine M
Davis, Thomas E
Schmeler, Kathleen M
Ferris, Daron G
Savage, Ashlyn H
Gray, Jermaine E
Stoler, Mark H
Wright, Jr, Thomas C
Ferenczy, Alex
Einstein, Mark H
description The Xpert HPV Assay (Xpert; Cepheid, Sunnyvale, CA) was developed for the multianalytic GeneXpert platform. In a colposcopy referral population of 708 women living in the United States, two cervical specimens, A and B, were collected, and both were tested by the Xpert assay for high-risk human papillomavirus (hrHPV) DNA, permitting an evaluation of its test reliability. Specimen B was also tested by Hybrid Capture 2 (hc2; Qiagen, Germantown, MD) and the cobas HPV Test (cobas; Roche Molecular Systems, Pleasanton, CA). The κ and percent agreement for any hrHPV for the two Xpert results were 0.88 and 94.5%, respectively. There was no statistical difference in testing positive on both specimens by Xpert (P = .62). The sensitivity for detection of cervical intraepithelial neoplasia grade 2 or more severe (CIN2+) was 89.0% using specimen A and 90.4% using specimen B for Xpert, 90.4% for cobas, and 81.6% for hc2. The Xpert assay was sensitive and reliable for the detection of hrHPV and the identification of women with CIN2+.
doi_str_mv 10.1309/AJCP4Q0NSDHWIZGU
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1637562308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3593325071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c327t-93d922fc39f616c9aa75b09194ab4992e293928024c86527232781056b0de1a93</originalsourceid><addsrcrecordid>eNpdkTlPAzEUhC0EgnD0VMgSDc2Cj71cRuFIEApnANGsvI6XGLxrY3uR8u8xIlDwmmm-Gb3RALCP0TGmiJ0ML0c36S2a3p-OnyYvF7M1MMAspUlRELIOBgghkjBc0C2w7f0bQpiUKN0EWyTLMMYZHgB_J7XitdIqLKFpYFhI-GylC3B88wi593wJg4FzGaQIcKFeF4lT_h0u-pZ30HKrtDYt_1Su9_B0OoSqgxwKo63xwtgldLKRznENrbG95kGZbhdsNFx7ubfSHTA7P3sYjZOr64vJaHiVCEqKkDA6Z4Q0grImx7lgnBdZjVgsyOuUMSIJoywWIqko84wUJLpKjLK8RnOJOaM74Ogn1zrz0UsfqlZ5IbXmnTS9r3BOiywnFJURPfyHvpnedfG7SGXx8jL9ptAPJZzxPjarrFMtd8sKo-p7kOr_INFysAru61bO_wy_C9Av43iGjg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655556848</pqid></control><display><type>article</type><title>Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Castle, Philip E ; Smith, Katherine M ; Davis, Thomas E ; Schmeler, Kathleen M ; Ferris, Daron G ; Savage, Ashlyn H ; Gray, Jermaine E ; Stoler, Mark H ; Wright, Jr, Thomas C ; Ferenczy, Alex ; Einstein, Mark H</creator><creatorcontrib>Castle, Philip E ; Smith, Katherine M ; Davis, Thomas E ; Schmeler, Kathleen M ; Ferris, Daron G ; Savage, Ashlyn H ; Gray, Jermaine E ; Stoler, Mark H ; Wright, Jr, Thomas C ; Ferenczy, Alex ; Einstein, Mark H</creatorcontrib><description>The Xpert HPV Assay (Xpert; Cepheid, Sunnyvale, CA) was developed for the multianalytic GeneXpert platform. In a colposcopy referral population of 708 women living in the United States, two cervical specimens, A and B, were collected, and both were tested by the Xpert assay for high-risk human papillomavirus (hrHPV) DNA, permitting an evaluation of its test reliability. Specimen B was also tested by Hybrid Capture 2 (hc2; Qiagen, Germantown, MD) and the cobas HPV Test (cobas; Roche Molecular Systems, Pleasanton, CA). The κ and percent agreement for any hrHPV for the two Xpert results were 0.88 and 94.5%, respectively. There was no statistical difference in testing positive on both specimens by Xpert (P = .62). The sensitivity for detection of cervical intraepithelial neoplasia grade 2 or more severe (CIN2+) was 89.0% using specimen A and 90.4% using specimen B for Xpert, 90.4% for cobas, and 81.6% for hc2. The Xpert assay was sensitive and reliable for the detection of hrHPV and the identification of women with CIN2+.</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1309/AJCP4Q0NSDHWIZGU</identifier><identifier>PMID: 25511151</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Cervical Intraepithelial Neoplasia - diagnosis ; Colposcopy ; Female ; Humans ; Molecular Diagnostic Techniques - methods ; Papillomavirus Infections - diagnosis ; Referral and Consultation ; Reproducibility of Results ; Sensitivity and Specificity ; Uterine Cervical Neoplasms - diagnosis</subject><ispartof>American journal of clinical pathology, 2015-01, Vol.143 (1), p.126-133</ispartof><rights>Copyright© by the American Society for Clinical Pathology.</rights><rights>Copyright American Society for Clinical Pathology Jan 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c327t-93d922fc39f616c9aa75b09194ab4992e293928024c86527232781056b0de1a93</citedby><cites>FETCH-LOGICAL-c327t-93d922fc39f616c9aa75b09194ab4992e293928024c86527232781056b0de1a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25511151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castle, Philip E</creatorcontrib><creatorcontrib>Smith, Katherine M</creatorcontrib><creatorcontrib>Davis, Thomas E</creatorcontrib><creatorcontrib>Schmeler, Kathleen M</creatorcontrib><creatorcontrib>Ferris, Daron G</creatorcontrib><creatorcontrib>Savage, Ashlyn H</creatorcontrib><creatorcontrib>Gray, Jermaine E</creatorcontrib><creatorcontrib>Stoler, Mark H</creatorcontrib><creatorcontrib>Wright, Jr, Thomas C</creatorcontrib><creatorcontrib>Ferenczy, Alex</creatorcontrib><creatorcontrib>Einstein, Mark H</creatorcontrib><title>Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population</title><title>American journal of clinical pathology</title><addtitle>Am J Clin Pathol</addtitle><description>The Xpert HPV Assay (Xpert; Cepheid, Sunnyvale, CA) was developed for the multianalytic GeneXpert platform. In a colposcopy referral population of 708 women living in the United States, two cervical specimens, A and B, were collected, and both were tested by the Xpert assay for high-risk human papillomavirus (hrHPV) DNA, permitting an evaluation of its test reliability. Specimen B was also tested by Hybrid Capture 2 (hc2; Qiagen, Germantown, MD) and the cobas HPV Test (cobas; Roche Molecular Systems, Pleasanton, CA). The κ and percent agreement for any hrHPV for the two Xpert results were 0.88 and 94.5%, respectively. There was no statistical difference in testing positive on both specimens by Xpert (P = .62). The sensitivity for detection of cervical intraepithelial neoplasia grade 2 or more severe (CIN2+) was 89.0% using specimen A and 90.4% using specimen B for Xpert, 90.4% for cobas, and 81.6% for hc2. The Xpert assay was sensitive and reliable for the detection of hrHPV and the identification of women with CIN2+.</description><subject>Cervical Intraepithelial Neoplasia - diagnosis</subject><subject>Colposcopy</subject><subject>Female</subject><subject>Humans</subject><subject>Molecular Diagnostic Techniques - methods</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Referral and Consultation</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkTlPAzEUhC0EgnD0VMgSDc2Cj71cRuFIEApnANGsvI6XGLxrY3uR8u8xIlDwmmm-Gb3RALCP0TGmiJ0ML0c36S2a3p-OnyYvF7M1MMAspUlRELIOBgghkjBc0C2w7f0bQpiUKN0EWyTLMMYZHgB_J7XitdIqLKFpYFhI-GylC3B88wi593wJg4FzGaQIcKFeF4lT_h0u-pZ30HKrtDYt_1Su9_B0OoSqgxwKo63xwtgldLKRznENrbG95kGZbhdsNFx7ubfSHTA7P3sYjZOr64vJaHiVCEqKkDA6Z4Q0grImx7lgnBdZjVgsyOuUMSIJoywWIqko84wUJLpKjLK8RnOJOaM74Ogn1zrz0UsfqlZ5IbXmnTS9r3BOiywnFJURPfyHvpnedfG7SGXx8jL9ptAPJZzxPjarrFMtd8sKo-p7kOr_INFysAru61bO_wy_C9Av43iGjg</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Castle, Philip E</creator><creator>Smith, Katherine M</creator><creator>Davis, Thomas E</creator><creator>Schmeler, Kathleen M</creator><creator>Ferris, Daron G</creator><creator>Savage, Ashlyn H</creator><creator>Gray, Jermaine E</creator><creator>Stoler, Mark H</creator><creator>Wright, Jr, Thomas C</creator><creator>Ferenczy, Alex</creator><creator>Einstein, Mark H</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>201501</creationdate><title>Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population</title><author>Castle, Philip E ; Smith, Katherine M ; Davis, Thomas E ; Schmeler, Kathleen M ; Ferris, Daron G ; Savage, Ashlyn H ; Gray, Jermaine E ; Stoler, Mark H ; Wright, Jr, Thomas C ; Ferenczy, Alex ; Einstein, Mark H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c327t-93d922fc39f616c9aa75b09194ab4992e293928024c86527232781056b0de1a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cervical Intraepithelial Neoplasia - diagnosis</topic><topic>Colposcopy</topic><topic>Female</topic><topic>Humans</topic><topic>Molecular Diagnostic Techniques - methods</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Referral and Consultation</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castle, Philip E</creatorcontrib><creatorcontrib>Smith, Katherine M</creatorcontrib><creatorcontrib>Davis, Thomas E</creatorcontrib><creatorcontrib>Schmeler, Kathleen M</creatorcontrib><creatorcontrib>Ferris, Daron G</creatorcontrib><creatorcontrib>Savage, Ashlyn H</creatorcontrib><creatorcontrib>Gray, Jermaine E</creatorcontrib><creatorcontrib>Stoler, Mark H</creatorcontrib><creatorcontrib>Wright, Jr, Thomas C</creatorcontrib><creatorcontrib>Ferenczy, Alex</creatorcontrib><creatorcontrib>Einstein, Mark H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castle, Philip E</au><au>Smith, Katherine M</au><au>Davis, Thomas E</au><au>Schmeler, Kathleen M</au><au>Ferris, Daron G</au><au>Savage, Ashlyn H</au><au>Gray, Jermaine E</au><au>Stoler, Mark H</au><au>Wright, Jr, Thomas C</au><au>Ferenczy, Alex</au><au>Einstein, Mark H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population</atitle><jtitle>American journal of clinical pathology</jtitle><addtitle>Am J Clin Pathol</addtitle><date>2015-01</date><risdate>2015</risdate><volume>143</volume><issue>1</issue><spage>126</spage><epage>133</epage><pages>126-133</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><abstract>The Xpert HPV Assay (Xpert; Cepheid, Sunnyvale, CA) was developed for the multianalytic GeneXpert platform. In a colposcopy referral population of 708 women living in the United States, two cervical specimens, A and B, were collected, and both were tested by the Xpert assay for high-risk human papillomavirus (hrHPV) DNA, permitting an evaluation of its test reliability. Specimen B was also tested by Hybrid Capture 2 (hc2; Qiagen, Germantown, MD) and the cobas HPV Test (cobas; Roche Molecular Systems, Pleasanton, CA). The κ and percent agreement for any hrHPV for the two Xpert results were 0.88 and 94.5%, respectively. There was no statistical difference in testing positive on both specimens by Xpert (P = .62). The sensitivity for detection of cervical intraepithelial neoplasia grade 2 or more severe (CIN2+) was 89.0% using specimen A and 90.4% using specimen B for Xpert, 90.4% for cobas, and 81.6% for hc2. The Xpert assay was sensitive and reliable for the detection of hrHPV and the identification of women with CIN2+.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>25511151</pmid><doi>10.1309/AJCP4Q0NSDHWIZGU</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9173
ispartof American journal of clinical pathology, 2015-01, Vol.143 (1), p.126-133
issn 0002-9173
1943-7722
language eng
recordid cdi_proquest_miscellaneous_1637562308
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Cervical Intraepithelial Neoplasia - diagnosis
Colposcopy
Female
Humans
Molecular Diagnostic Techniques - methods
Papillomavirus Infections - diagnosis
Referral and Consultation
Reproducibility of Results
Sensitivity and Specificity
Uterine Cervical Neoplasms - diagnosis
title Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A30%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reliability%20of%20the%20Xpert%20HPV%20assay%20to%20detect%20high-risk%20human%20papillomavirus%20DNA%20in%20a%20colposcopy%20referral%20population&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=Castle,%20Philip%20E&rft.date=2015-01&rft.volume=143&rft.issue=1&rft.spage=126&rft.epage=133&rft.pages=126-133&rft.issn=0002-9173&rft.eissn=1943-7722&rft_id=info:doi/10.1309/AJCP4Q0NSDHWIZGU&rft_dat=%3Cproquest_cross%3E3593325071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1655556848&rft_id=info:pmid/25511151&rfr_iscdi=true